Through further analysis of GOT1 with the Oncomine database, we found the GOT1 gene expression levels to vary in different types of cancers, for instance the GOT1 expression was up-regulated in breast and lung cancer [9–12], while down-regulated in brain and colorectal cancer [13–16]. The gene discussed is GOT1; the disease is colorectal cancer.